This Slide: #53 of 100 |
Slide #53. Perrigo Company plc — Elan Corporation, plc
Acquirer:
Perrigo Company plc (NYSE:PRGO)
Acquiree:
Elan Corporation, plc
Details:
Perrigo Company plc (NYSE, TASE: PRGO) ("Perrigo") and Elan Corporation, plc ("Elan") today announced that Perrigo has completed the acquisition of Elan in a cash and stock transaction valued on the date of the announcement at approximately US$8.6 billion. The transaction will create a global healthcare company with an industry-leading growth profile and the geographic scale and scope to continue building a truly differentiated business.
Perrigo is a provider of over-the-counter health and wellness solutions that can be self-managed. Co.'s segments are as follows: Consumer Self-Care Americas, which is focused primarily on the sale of self-care products in categories including upper respiratory, pain and sleep-aids, digestive health, nutrition, vitamins, minerals and supplements; Consumer Self-Care International, which develops, manufactures, markets, and distributes European consumer self-care brands in the upper respiratory, pain and sleep-aids, digestive health, vitamins, minerals and supplements; and Prescription Pharmaceuticals, which develops, manufactures, and markets a portfolio of generic prescription drugs.
PRGO SEC Filing Email Alerts Service
Open the PRGO Page at The Online Investor »
|
Open the PRGO Page at The Online Investor (in a new window) »
Free PRGO Email Alerts: Get SEC Filing Alerts Get Dividend Alerts |
Strong Buy (4.00 out of 4) 82nd percentile
(ranked higher than approx. 82% of all stocks covered)
Analysts' Target Price: PRGO Stock Forecast Based on Zacks ABR data; powered by Xignite |